Extended-duration betrixaban reduces the risk of stroke versus standard-dose enoxaparin among hospitalized medically ill patients: an APEX trial substudy (acute medically ill venous thromboembolism prevention with extended duration betrixaban) - Gibson, C M; Chi, G; Halaby, R (Circulation, 2017)
, et al; APEX Investigators.